![](/img/cover-not-exists.png)
210P Survival outcomes after toxicity-related dose modification of 5-fluorouracil, leucovorin and oxalipatin (FOLFOX) in stage III, resected colorectal cancer patients
Ha, F.J., Aksakal, G., Chong, G.Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw581.043
Date:
December, 2016
File:
PDF, 70 KB
2016